All International sources
| Title | Link |
|---|---|
| Keith E. Maskus - Parallel Imports in Pharmaceuticals: Implications for Competition and Prices in Developing Countries - Final Report to WIPO - April 2001 - (85 pages) | http://www.wipo.int/about-ip/en/studies/pdf/ssa_maskus_pi.pdf |
| Christopher Heath - Parallel Imports and International Trade - WIPO - (12 pages) | http://www.wipo.org/sme/en/documents/pdf/atrip_gva_99_6.pdf |
| K Balasubramaniam - Equitable Pricing, Affordability and Access to Essential Drugs in Developing Countries: Consumers Perspective - WTO - (12 pages) | http://www.wto.org/english/tratop_e/trips_e/hosbjor_presentations_e/35balasubramaniam_e.pdf |
| WHO - Lignes Directrices Opérationnelles pour les Comités d’Ethique chargés de l’évaluation de la Recherche Biomédicale - 2000 - (19 pages) | http://www.who.int/tdr/publications/publications/pdf/ethicsfr.pdf |
| Critique internationale des essais suisses de prescription d’héroïne Rapport de la Commission externe d’experts de l’OMS Prises de position de l’Organe international de contrôle des stupéfiants (OICS) - (53 pages) | http://www.aegd.ch/pdf/kritik_franz.PDF |
| Helsinki Declaration - World Medical Association - Ethical Principles for Medical Research Involving Human Subjects - last amendment 52nd WMA General Assembly, Edinburgh, Scotland, October 2000 - (5 pages) | http://www.wma.net/e/policy/17c.pdf |
| WTO - Ministerial Declaration - Adopted on 14 November 2001 - (10 pages) | http://www.wto.org/english/thewto_e/minist_e/min01_e/mindecl_e.pdf |
| WTO -Declaration on the TRIPS Agreement and Public Health - Adopted on 14 November 2001 - (2 pages) | http://www.wto.org/english/thewto_e/minist_e/min01_e/mindecl_trips_e.pdf |
| WTO - Implementation-Related Issues and Concerns - Decision of 14 November 2001 - (8 pages) | http://www.wto.org/english/thewto_e/minist_e/min01_e/mindecl_implementation_e.pdf |
| Conseil de l'Europe Comité des Ministres Recommandation No R(90)3 du Comité des Ministres aux Etats membres sur la recherche médicale sur l'être humain adoptée par le Comité des Ministres le 6 février 1990 | http://www.inserm.fr/ethique/Ethique.nsf/397fe8563d75f39bc12563f60028ec43/325e8f4b601fa154c125675400383408?OpenDocument |
| COMITE
DIRECTEUR POUR LA BIOETHIQUE (CDBI) - Développement dans le domaine de
la bioéthique dans les Etats membres, dans les autres Etats et dans les organisations internationales - Strasbourg, le 26 Octobre 2001 - (83 pages) |
http://www.legal.coe.int/bioethics/pdf/CDBI-INF(2001)6F.pdf |
| CIOMS - International Ethical Guidelines for Biomedical Research Involving Human Subjects - Revised draft, January 2002 | http://www.cioms.ch/frame_guidelines_january_2002.htm |
| CIOMS - The Declaration of Inuyama - Human Genome Mapping, Genetic Screening and Gene Therapy | http://www.cioms.ch/frame_1990_texts_of_guidelines.htm |
| CIOMS - International Guiding Principles for Biomedical Research Involving Animals (1985) | http://www.cioms.ch/frame_1985_texts_of_guidelines.htm |
| Global Forum for Health Research - home page - "to help correct the 10/90 gap by focusing research efforts on diseases representing the heaviest burden on the world's health " | http://www.globalforumhealth.org/pages/index.asp |
| Global Forum for Health Research - Monitoring Financial Flows for Health Research (publication of 5 chapters) | http://www.globalforumhealth.org/FilesUpld/20.pdf |
| Global Forum for Health Research - The 10/90 Report on Health Research 2000 - (publication of 7 chapters) | http://www.globalforumhealth.org/non_compliant_pages/report00/00intro.pdf |
| WHO WTO - Report of the Workship on differential pricing and financing of essential Drug - April 2001 - (27 pages) | http://www.who.int/medicines/library/edm_general/who-wto-hosbjor/wholereporthosbjorworkshop-fin-eng.pdf |
| S. Jacobzone - Pharmaceutical Policies on OECD Countries : Reconciling Social and Industrial Goals - Labour Market and Social Policy - Occasional Papers No. 40 - (100 pages) | http://www.olis.oecd.org/OLIS/2000DOC.NSF/c5ce8ffa41835d64c125685d005300b0/c125685b0057c558c12568c400331a1e/$FILE/00075948.PDF |
| ICH - Guidance for Industry E 10 Choice of Control Group and Related Issues in Clinical Trials - May 2001 - (37 pages) | http://www.fda.gov/cder/guidance/4155fnl.pdf |
| U.S. - EC MRA (Mutual Recognition Agreement) Pharmaceutical Good Manufacturing Practices Annex - Sectoral Annex for Pharmaceutical Good Manufacturing Practices GMPs) - (29 pages) | http://pharmacos.eudra.org/F2/mra/doc/mraecus.pdf |
| U.S. - EC MRA - Joint Procedure for the Information Exchange of Serious or Life-Threatening Human / Animal Pharmaceutical Product Quality Defects and Recalls - (7 pages) | http://www.emea.eu.int/pdfs/technical/mra/usa/008600en.pdf |
| WHO - WHO Technical Report Series, No. 850, 1995, Annex 3 - Guidelines for good clinical practice (GCP) for trials on pharmaceutical products - (35 pages) | http://www.who.int/medicines/library/par/ggcp/GCPGuidePharmatrials.pdf |
| WHO - General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine - (80 pages) | http://www.who.int/medicines/library/trm/who-edm-trm-2000-1/who-edm-trm-2000-1.pdf |
| WHO - Criteria for Medicinal Drug Promotion - (8 pages) | http://www.who.int/medicines/library/dap/ethical-criteria/criteriamedicinal.pdf |
| WHO, MSF and others - Sources and prices of selected drugs and diagnostics for people living with HIV/AIDS. May 2001 - (38 pages) | http://www.who.int/medicines/library/par/hivrelateddocs/sourcesandprices31may01.pdf |
| WHO and UNAIDS - Patent situation of HIV/AIDS-related drugs in 80 countries - Geneva, January 2000 - (16 pages) | http://www.who.int/medicines/library/par/hivrelateddocs/patentshivdrugs.pdf |
| WIPO (monthly) magazine 2002 (access to pdf files) | http://www.wipo.org/publications/general/121/2002/index.html |
| WHO - Application for Inclusion of didanosine on WHO Model List of Essential Medicines | http://www.who.int/medicines/organization/par/edl/didanosine.doc |
| WHO - Legal Status of Traditional Medicine and Complementary/Alternative Medicine: A Worldwide Review - (199 pages) | http://www.who.int/medicines/library/trm/who-edm-trm-2001-2/LegalStatus-final.pdf |
| ILO - International Labour Organization - An ILO code of practice on HIV/AIDS and the world of work - 2001 - (38 pages) | http://www.ilo.org/public/english/protection/trav/aids/download/pdf/hiv_a4_e.pdf |
| Oxfam - TRIPS and Public Health The next battle - (18 pages) | http://www.cptech.org/files/Oxfam-Int-TRIPSPublicHealth.doc |
| ICH - Technical Requirements for Registration of Pharmaceuticals for Human Use - ICH M2 EWG Electronic Common Technical Document Specification - 2002 - (160 pages) | http://www.fda.gov/cder/m2/eCTD%20Step%202/eCTD%20Specification%20v2-0-1.pdf |
| WHO - Draft Scaling Up Antiretroviral Therapy in Resource Limited Settings : Guidelines for a Public Health Approach - 2002 - (115 pages) | http://www.who.int/HIV_AIDS/HIV_AIDS_Care/ARV_Draft_April_2002.pdf |
| C. Correa - Patent Law, TRIPS, and R&D Incentives: A Southern Perspective - CMH Working Paper Series Paper No. WG2: 12 - (35 pages) | http://www3.who.int/whosis/cmh/cmh_papers/e/pdf/wg2_paper11.pdf |
| Recent Developments and Challenges in the Protection of intellectual property rights pharmaceuticals and biotechnological Inventions - May 2001 - (24 pages) | http://www.wipo.org/ip-conf-bg/en/documents/pdf/sof01_2_5.pdf |
| Priced out of Reach - How WTO patent policies will reduce access to medicines in the developing world - Oxfam 4 | http://www.oxfam.org.uk/policy/papers/priced/priced.rtf |
| WTO Patent Rules and Access to Medicines: The Pressure Mounts - June 2001 - Oxfam | http://www.oxfam.org.uk/policy/papers/wtorules/wtorules.rtf |
| Brian Martin - Against intellectual property - (28 pages) | http://www.uow.edu.au/arts/sts/bmartin/pubs/98il/il03.pdf |
| Geoff Tansey - Food, Power, Intellectual Property and Traditional Knowledge – A Food Systems Overview -UNCTAD Expert Meeting - 2000 - (22 pages) | http://www.unctad.org/trade_env/docs/tansey.pdf |
| Literature survey on intellectual property rights and sustainable human development Selected and compiled by Graham Dutfield February 2002 | http://www.ictsd.org/unctad-ictsd/docs/bioblipr.pdf |
| The 10/90 Report on Health Research 2001-2002 - Health research and global security - April 2002 | http://www.globalforumhealth.org/FilesUpld/24.pdf http://www.globalforumhealth.org/FilesUpld/25.pdf http://www.globalforumhealth.org/FilesUpld/27.pdf |
| WHO, WHO medicines strategy Expanding access to essential drugs Report by the Secretariat - (6 pages) | http://www.who.int/gb/EB_WHA/PDF/WHA55/ea5512.pdf |
| The Multilateral Trading System: A Development Perspective - Third World Network December 2001 United Nations Development Programme - (103 pages) | http://www.undp.org/mainundp/propoor/docs/TWN%20text%20jan11.pdf |
| UNDP - Global initiatives to create technologies for human development - Chapter 5 - (36 pages) | http://www.undp.org/hdr2001/chapterfive.pdf |
| WIPO - Striking a Balance: Patents and Access to Drugs and Health Care | http://www.wipo.int/about-ip/en/studies/publications/health_care.htm |
| Haiweb - NGO statement on Drug Policy at the 55th World Health Assembly May 2002: "Ensuring Accessibility of Essential Medicines" Resolution EB109.R17 | http://www.haiweb.org/campaign/access/wha55/WHA55briefing.doc |
| IFPMA Code of Pharmaceutical Marketing Practices | http://www.ifpma.org/ifpma4.html |
| IFPMA International Pharmaceutical Issues | http://www.ifpma.org/ifpma8a.html |
| OECD - The OECD Guidelines for Multinational Enterprises Revision 2000 - (67 pages) | http://www.oecd.org/pdf/M000015000/M00015419.pdf |
| OECD - The OECD Declaration and Decisions on International Investment and Multinational Enterprises : Basic Texts - (35 pages) | http://www.olis.oecd.org/olis/2000doc.nsf/c5ce8ffa41835d64c125685d005300b0/c125692700623b74c1256991003b5147/$FILE/00085743.PDF |
| ICH M2 EWG Electronic Common Technical Document Specification- Technical Requirements for registration of pharmaceuticals for human use - February 12, 2002 - (160 pages) | http://www.fda.gov/cder/guidance/5017dft.pdf |
| ICH Q1E - Draft Consensus Guideline Evaluation of Stability Data - 7 February 2002 | http://www.fda.gov/cder/guidance/4983dft.pdf |
| ICH Q1F Draft Consensus Guideline - Stability Data Package for Registration in Climatic Zones III and IV - February 7, 2002 - (5 pages) | http://www.fda.gov/cder/guidance/4984dft.pdf |
| WHO - Operational Guidelines for Ethics Committees That Review Biomedical Research - 2000 - (39 pages) | http://www.who.int/tdr/publications/publications/pdf/ethics.pdf |
| Constitution de l'Organisation mondiale de la santé du 22 juillet 1946; RS 0.810.1 | http://www.admin.ch/ch/f/rs/i8/0.810.1.fr.pdf |
| Convention du 8 octobre 1970 pour la reconnaissance mutuelle des inspections concernant la fabrication des produits pharmaceutiques (avec notes explicatives); RS 0.812.101 | http://www.admin.ch/ch/f/rs/i8/0.812.101.fr.pdf |
| Stability Testing of New Drug Substances and Products (Step 5) | http://www.ifpma.org/pdfifpma/q1arstep4.pdf |
| Guideline on Photostability Testing (Step 5) | http://www.ifpma.org/pdfifpma/q1b.pdf |
| Guideline on Stability Testing for New Dosage Forms Step 5 | http://www.ifpma.org/pdfifpma/q1c.pdf |
| Guideline on Impurities in New Drug Substances (Revised Guideline) (Step 3) | http://www.ifpma.org/word/Q3Arstep2.doc |
| Impurities in New Drug Products (Revised Guideline) (Step 3) | http://www.ifpma.org/word/Q3Brstep2.doc |
| Q6B Guideline on Biotechnological Substances (Step 5) | http://www.ifpma.org/pdfifpma/Q6bstep4.pdf |
| Q7A Guideline on Good Manufacturing Practices for Active Pharmaceutical Ingredients Step 5 | http://www.ifpma.org/pdfifpma/Q7Astep4.PDF |
| The Pharmaceutical Research and Manufacturers of America (PhRMA) - home page | http://www.phrma.org/ |
| World Intellectual Property Organization - home page | http://www.wipo.org/ |
| Accord entre la Communauté européenne et la Confédération suisse relatif à la reconnaissance mutuelle en matière d’évaluation de la conformité - FF 1999 5847 - (80 pages) | http://www.europa.admin.ch/ba/off/abkommen/f/abf_tbt.pdf |
| WIPO, Parallel Imports in Pharmaceuticals: Implications for Competition and Prices in Developing Countries | http://www.wipo.org/about-ip/en/studies/pdf/ssa_maskus_pi.pdf |
| WIPO, Rules of Arbitration | http://arbiter.wipo.int/arbitration/arbitration-rules/complete.html |
| WIPO, Patent applications filed and patents granted during 1998 by country | http://www.wipo.int/ipstats/en/publications/b/1998/i/pattab1.pdf |
| WIPO, Broad Summary of Patents figures - 1998 - | http://www.wipo.int/ipstats/en/publications/b/1998/i/broad1.pdf |
| WIPO, Introduction to the Internaitonal phase of the PCT | http://www.wipo.org/pct/guide/en/gdvol1/pdf/gdvol1.pdf |
| WIPO, Introduction to the national phase of the PCT | http://www.wipo.org/pct/guide/en/gdvol2/pdf/gdvol2.pdf |
| WIPO, Rules of the Patent Cooperation Treaty - PCT | http://www.wipo.org/pct/en/texts/articles/atoc.htm |
| WIPO, Regulations under the Patent Cooperation Treaty (PCT) | http://www.wipo.org/pct/en/texts/pdf/pct_regs.pdf |
| WIPO, Administration instructions under the Patent Cooperation Treaty (PCT) - (89 pages) | http://www.wipo.org/pct/en/texts/pdf/ai_01.pdf |
| Convention for the Protection of Human Rights and Dignity of the Human Being with regard to the Application of Biology and Medicine (Convention on Human Rights and Biomedicine) (Oviedo Convention) - April 4, 1997 | http://www.legal.coe.int/bioethics/gb/pdf/convention.pdf |
| Explanatory Report to the Convention for thze Protection of human rights and dignity of the human being with regard to the application of biology and medicine convention on human rights and biomedicines - 36 pages) | http://www.legal.coe.int/bioethics/gb/pdf/rapport.pdf |
| Council of Europe - Recommendation 934 (1982) on genetic engineering | http://stars.coe.fr/ta/ta82/erec934.htm |
| Council of Europe - Recommendation 1046 (1986) on the use of human embryos and foetuses for diagnostic, therapeutic, scientific, industrial and commercial purposes | http://stars.coe.fr/ta/ta86/erec1046.htm |
| Council of Europe - RECOMMENDATION 1100 (1989)1 on the use of human embryos and foetuses in scientific research | http://stars.coe.fr/ta/ta89/erec1100.htm |
| Council of Europe - Recommendation 1240 (1994) on the protection and patentability of material of human origin | http://stars.coe.fr/ta/ta94/erec1240.htm |
| Council of Europe - Recommendation 1425 (1999) on Biotechnology and intellectual property | http://stars.coe.fr/ta/ta99/erec1425.htm |
| Council of Europe - Recommendation 1512 (2001) on the Protection of the human genome by the Council of Europe | http://stars.coe.fr/ta/TA01/EREC1512.htm |
| Council of Europe - Additional Protocol to the Oviedo Convention on the Prohibition of Cloning Human Beings and Explanatory report to the Protocol | http://www.legal.coe.int/bioethics/gb/pdf/proto.pdf |
| IBC, International Bioethics Committee - Working Group on genetic data - Draft Report on Collection, Treatment, Storage and Use of Genetic Data - September 3, 2001 | http://www.unesco.org/ibc/en/reports/DraftRep_UseOf_GenData_E.pdf |
| International Bioethics Committee (IBC)- The Use of Embryonic Stem Cells In Therapeutic Research - April 6, 2001 - (24 pages) | http://www.unesco.org/ibc/en/reports/embryonic_ibc_report.pdf |
| The International Organization for Standardization (ISO) - home page - "a non-governmental organization" & "a worldwide federation of national standards bodies from some 140 countries, one from each country". | http://www.iso.ch/iso/en/ISOOnline.openerpage |
| Council of Europe, Convention for the Protection of Human Rights and Fundamental Freedoms as amended by Protocol No. 11 with Protocol Nos. 1, 4, 6 and 7 | http://www.echr.coe.int/Convention/webConvenENG.pdf |
| Council of Europe - home page | http://www.coe.int/portalT.asp |
| Council of Europe - Public Health page | http://www.coe.fr/soc-sp/sante/default_eng.htm |
| Public Health Committee - Committee of experts on cosmetic products -"Indicative catalogue of criteria for delimiting borderline situations between cosmetic and medicinal products" | http://www.coe.fr/soc-sp/sante/Cosm%20claims%20catalogue.htm |
| Council of Europe - Cosmétiques naturels - Notice of information to consumers | http://www.coe.fr/soc-sp/sante/nat%20cosm.htm |
| List of medicines subject to prescription, 2000 edition | http://www.coe.fr/soc-sp/sante/Alpha%20List%202000%20E.zip |
| Council of Europe - Committee of Ministers - Resolution AP(2000) on the classification of medicines which are obtainable only on medical prescription - March 15, 2000 | http://cm.coe.int/ta/res/resAP/2000/2000xp1.htm |
| Council of Europe - Committee of Ministers . Resolution AP (99) 2- on warning phrases for certain categories of medicines | http://www.coe.fr/cm/ta/res/resAP/1999/99xp2.htm |
| Council of Europe - Committee of Ministers - Resolution AP (96) - on the declaration of excipients present in pharmaceutical products - October 2, 1996 | http://cm.coe.int/ta/res/1996/96xp1.html |
| Public Health Committee - Committe of experts on pharmaceutical questions - Note from the Austrian Delegation on the requirements applying to prescriptions - Medicines for human use except narcotics | http://www.coe.fr/soc-sp/sante/97spt19reve.zip |
| Public Health Committe - Committee of experts on pharmaceutical questions - Final Report on Generic Medicines - April 2000 | http://www.coe.fr/soc-sp/sante/CD-P-SPT%20(2000)%2027%20E%20-generic%20medicines.zip |
| Council of Europe - comparisons of regulations applying to vitamins | http://www.coe.fr/soc-sp/sante/CD-P-SPT%20(98)%2024E%20-Vitamin%20products.zip |
| Public Health Committee - Committee of experts on pharmaceutical questions - Final Report on the importation of unregistered medicines - Multicountry comparisons - April 2000 | http://www.coe.fr/soc-sp/sante/SPT28E%20-%20médicaments%20non%20enregistrés%20-%20Autriche.zip |
| Council of Europe's Policy Statements concerning nutrition, food safety and Consumer Health - Technical document - Guidelines concering scientific substantiation of health-related claims for functional food | http://www.coe.fr/soc-sp/sante/functfood.ZIP |
| Council of Europe - Public Health Committee - Energy Drinks - Information Note to Consumers - May 2001 | http://www.coe.fr/soc-sp/sante/energ_drinks.htm |
| Special Programme for Research and Training in Tropical Diseases (TDR) - home page - "TDR focuses on neglected infectious diseases that disproportionally affect poor and marginalized populations" | http://www.who.int/tdr/ |
| United Nations Development Programme - home page - "UNDP provides funds; helps developing countries attract and use aid effectively" | http://www.undp.org/ |
| World Bank - home page - "one of the world's largest sources of development assistance. In Fiscal Year 2001, the institution provided more than US$17 billion in loans to its client countries" | http://www.worldbank.org/ |
| World Bank - Health, Nutrition, and Population Sector Strategy Paper - (93 pages) | http://wbln0018.worldbank.org/HDNet/hddocs.nsf/c840b59b6982d2498525670c004def60/80ac87ad5b7910c4852568f20051bdcc/$FILE/hnp.pdf |
| Unaids - Progress report - ACCELERATING ACCESS TO HIV/AIDS CARE, TREATMENT AND SUPPORT - Updated November 2001 - (23 pages) | http://www.unaids.org/acc_access/AAprogress1101.doc |
| European Patent Office - Annual Report 2000 - (80 pages) | http://www.european-patent-office.org/epo/an_rep/2000/pdf/fulldoc.pdf |
| Fees under the European Patent Organisation - Rules relating to fees of 20 October 1977 as last amended by decision of the Administrative Council of the European Patent Organisation | http://www.european-patent-office.org/epo/ca/e/28_06_01.htm |
| EPO boards of appeal decisions - monthly update | http://www.european-patent-office.org/dg3/updates/index.htm |
| EPO Enlarged boards of appeal decisions | http://www.european-patent-office.org/dg3/g_dec/index.htm |
| Decision of the Enlarged Board of Appeal regarding the application of Article 53(b) EPC to transgenic plant varieties | http://www.european-patent-office.org/dg3/g_dec/pdf/g980001.pdf |
| Decision of the Enlarged Board of Appeal - December 18, 1992- State of prior art for chemical compositions | http://www.european-patent-office.org/dg3/g_dec/pdf/g920001.pdf |
| Decision of the Enlarged Board of Appeal - EPO - December 5, 1984 - regarding patent on second medical use | http://www.european-patent-office.org/dg3/g_dec/pdf/g830006.pdf |
| EPC - European Patent Convention - (511 pages) | http://www3.european-patent-office.org/dwld/epc/epc_2000.pdf |
| Ancillary Regulations to the European Patent Convention | http://www.european-patent-office.org/legal/anc_reg/e/index.htm |
| Case Law of the Boards of Appeal by themes | http://www.european-patent-office.org/legal/case_law/e/index.htm |
| EPO - Guidelines for examination in the European Patent Office - (466 pages) | http://www.european-patent-office.org/legal/gui_lines/pdf/gui_e_full.pdf |
| International Patent Classification | http://classifications.wipo.int/fulltext/new_ipc/index.htm |
| Introductory Manual to the IPC (International Patent Classification | http://www.wipo.int/classifications/en/index.html |
| WIPO - Patent Protection and Access to HIV / AIDS Phamaceuticals in Sub-Saharan Africa - (105 pages) | http://www.wipo.int/about-ip/en/studies/pdf/iipi_hiv.pdf |
| WHO - Globalization and Access to Drugs - Perspectives on the WTO/TRIPS Agreement (111 pages) | http://www.who.int/medicines/library/dap/who-dap-98-9-rev/who-dap-98-9rev.pdf |
| WHO - Globalization, Patents and Drugs: An Annotated Bibliography - 2001 - (64 pages) | http://www.who.int/medicines/library/par/who-edm-par-2001-1/who-edm-par-2001-1.pdf |
| WHO - Health Reform and Drug Financing: Selected Topics - 1998 - (62 pages) | http://www.who.int/medicines/library/dap/who-dap-98-3/who-dap-98-3.pdf |
| WHO - Global Strategy for Containment of Antimicrobial Resistance - 2001 - (105 pages) | http://www.who.int/emc/amrpdfs/WHO_Global_Strategy_English.pdf |
| WHO - Model list of Essential Drugs - (14 pages) | http://www.who.int/medicines/organization/par/edl/edl11.pdf |
| WHO - The definition and selection process for an EDL (essential drug list) - Technical Briefing Paper - 27 October 2000 | http://www.who.int/medicines/organization/par/edl/infedltechbrief.htm |
| WHO - Herbal medicines - Assessment of safety and efficacy | http://www.who.int/medicines/library/trm/medicinalplants/assessdocs.shtml |
| WHO - Acupuncture | http://www.who.int/medicines/library/trm/acupuncture/acupdocs.shtml |
| WHO - Biotechnology and Food Safety - Report of a Joint FAO/WHO Consultation | http://www.fao.org/WAICENT/faoinfo/economic/esn/biotech/tabconts.htm |
| Codex Alimentarius Commission - home page | http://www.codexalimentarius.net/ |
| WHO - Model Certificate of a Pharmaceutical Product | http://www.who.int/medicines/organization/qsm/activities/drugregul/certification/modcert.html |
| WHO - Guidelines on the implementation of the WHO certification scheme on the quality of pharmaceutical products moving in international commerce | http://www.who.int/medicines/organization/qsm/activities/drugregul/certification/certifguide.html |
| WHO - Achieving balance in national opioids control policy -- Guidelines for assessment - 2000 - (45 pages) | http://www.who.int/medicines/library/qsm/who-edm-qsm-2000-4/Balance%20in%20Nat%20Opioids%20Control%20Policy%20final.pdf |
| International Narcotics Control Board - home page | http://www.incb.org/ |
| WHO - Good Manufacturing Practices | http://www.who.int/medicines/organization/qsm/activities/qualityassurance/gmp/gmpcover.html |
| International Conference on Harmonisation - ICH - home page | http://www.ifpma.org/ich1.html |
| ICH - Harmonisation process | http://www.ifpma.org/ich4.html |
| ICH - list of guidelines | http://www.ifpma.org/ich5.html |
| Executive Committee Meeting in Sorrento 2000 - Summary Report - Patentability Requirements and Scope of Protection of Expressed Sequence Tags (ESTs), Single Nucleotide Polymorphisms (SNPs) and Entire Genomes | http://www.aippi.org/reports/q150/sr-q150-e.htm |
| International Association for the Protection of Intellectual Property - home page | http://www.aippi.org |
| AIPPI - Publications | http://www.aippi.org/services-online-publications.html |
| WTO - Uruguay Round Final Act: full texts | http://www.wto.org/english/docs_e/legal_e/final_e.htm |
| WTO - Council for Trade-Related Aspects of Intellectual Property Rights - Document prepared by the International Bureau of WIPO for the Meeting on Intellectual on Genetic Resources - An Overview | http://docsonline.wto.org/_ |
| WTO - THE RELATIONSHIP BETWEEN THE CONVENTION ON BIOLOGICAL DIVERSITY (CBD) AND THE AGREEMENT ON THE TRADE-RELATED ASPECTS OF INTELLECTUAL PROPERTY RIGHTS (TRIPS); | http://docsonline.wto.org/_ |
| Convention unique sur les stupéfiants de 1961 - conclue à New York le 30 mars 1961 - Signée par la Suisse le 20 avril 1961 - RS 0.812.121.0 | http://www.admin.ch/ch/f/rs/i8/0.812.121.0.fr.pdf |
| Protocole portant amendement de la Convention unique sur les stupéfiants de 1961 - Conclu à Genève le 25 mars 1972 - Approuvé par l’Assemblée fédérale le 21 mars 1995 - RS 0.812.121.01 | http://www.admin.ch/ch/f/rs/i8/0.812.121.01.fr.pdf |
| Convention sur les substances psychotropes - Conclue à Vienne le 21 février 1971 - Entrée en vigueur pour la Suisse le 21 juillet 1996 - RS 0.812.121.02 | http://www.admin.ch/ch/f/rs/i8/0.812.121.02.fr.pdf |
| Convention internationale de l’opium - Conclue à La Haye le 23 janvier 1912 -Entrée en vigueur pour la Suisse le 15 janvier 1925 - RS 0.812.121.2 | http://www.admin.ch/ch/f/rs/i8/0.812.121.2.fr.pdf |
| Protocole amendant les accords, conventions et protocoles sur les stupéfiants - Entré en vigueur pour la Suisse le 25 septembre 1947 - RS 0.812.121.21 | http://www.admin.ch/ch/f/rs/i8/0.812.121.21.fr.pdf |
| Protocole visant limiter et à réglementer la culture du pavot, ainsi que la production, le commerce international, le commerce de gros et l’emploi de l’opium - conclu à New York le 23 juin 1953 - RS 0.812.121.3 | http://www.admin.ch/ch/f/rs/i8/0.812.121.3.fr.pdf |
| Convention internationale relative stupéfiants - conclue à Genève le 19 février 1925 - entrée en vigueur pour la Suisse le 2 juillet 1929 - RS 0.812.121.4 | http://www.admin.ch/ch/f/rs/i8/0.812.121.4.fr.pdf |
| Convention pour limiter la fabrication et réglementer la distribution des stupéfiants - conclue à Genève le 13 juillet 1931 - entrée en vigueur pour la Suisse le 9 juillet 1933 - RS 0.812.121.5 | http://www.admin.ch/ch/f/rs/i8/0.812.121.5.fr.pdf |
| Protocole du 19 novembre 1948 plaçant sous contrôle international certaines drogues non visées par la Convention du 13 juillet 1931 - entré en vigueur pour la Suisse le 18 mars 1953 - RS 0.812.121.52 | http://www.admin.ch/ch/f/rs/i8/0.812.121.52.fr.pdf |
| Convention du 26 juin 1936 pour la répression du trafic illicite des drogues nuisibles - conclue à Genève, le 26 juin 1936 - entrée en vigueur pour la Suisse le 31 mars 1953 - RS 0.812.121.6 | http://www.admin.ch/ch/f/rs/i8/0.812.121.6.fr.pdf |
| Convention contre le dopage - conclue à Strasbourg le 16 novembre 1989 - entrée en vigueur pour la Suisse le 1er janvier 1993 - RS 0.812.122.1 | http://www.admin.ch/ch/f/rs/i8/0.812.122.1.fr.pdf |
| Accord européen relatif à l’échange de substances thérapeutiques d’origine humaine - conclu à Paris le 15 décembre 1958 - entré en vigueur pour la Suisse le 1er décembre 1965 - RS 0.812.161 | http://www.admin.ch/ch/f/rs/i8/0.812.161.fr.pdf |
| Convention relative à l’élaboration d’une Pharmacopée Européenne - conclue à Strasbourg le 22 juillet 1964 - entrée en vigueur pour la Suisse le 8 mai 19742 - RS 0.812.21 | http://www.admin.ch/ch/f/rs/i8/0.812.21.fr.pdf |
| OECD - Biotechnology and Food Safety - home page | http://www1.oecd.org/subject/biotech/ |
| OECD .- Ad Hoc Group on Food Safety - Overview of National Food Safety Systems and Activities - (12 pages) | http://www1.oecd.org/subject/biotech/overview_nfssa.pdf |
| OECD - GM Food Safety : Facts, Uncertainties and Assessment - February March 2000 - Raporteur's summary - (11 pages) | http://www1.oecd.org/subject/biotech/Rapporteureng.pdf |
| OECD - Working Party on Biotechnology - Health Policy Brief - Data Protection in Transborder Flows of Health Research Data - December 1999 - (33 pages) | http://www.olis.oecd.org/olis/1999doc.nsf/8358a613ec4462afc12569fa005d1700/c9c84852a946479cc12568430057171b/$FILE/12E93887.ENG |
| OECD - The Economic Aspects of Biotechnologies related to Human Health Part I - 1998 - (72 pages) | http://www1.oecd.org/dsti/sti/s_t/biotech/prod/health.pdf |
| OECD - Working Party on Biotechnology - Economic Aspects of Biotechnologies related to Human Health - 1998 - (269 pages) | http://appli1.oecd.org/olis/1998doc.nsf/4cf568b5b90dad994125671b004bed59/f38277100c7a721bc12566b1006273a6/$FILE/11E88111.ENG |
| OECD - Food Safety and Quality -1999 - (82 pages) | http://www1.oecd.org/subject/biotech/5199081e.pdf |
| OECD - Intellectual Property, Technology Transfer and Genetic Resources - an OECD Survey of current practices and policites - (81 pages) | http://www1.oecd.org/dsti/sti/s_t/biotech/prod/ipr.pdf |
| OECD - home page | http://www.oecd.org |
| OECD - Directorate for Science, Technology and Industry - Committee for Scienttific and Technological Policy - Working Party on Biotechnology - Consultation on Xenotransplantation Surveillance : Summary Report - (51 pages) | http://www.olis.oecd.org/olis/2001doc.nsf/c5ce8ffa41835d64c125685d005300b0/7d4e7b2820d508dfc1256af1005328fc/$FILE/JT00115450.PDF |
| OECD - Science Technology Industry - University Research in Transition - 1999 - (98 pages) | http://www.oecd.org/pdf/M000014000/M00014817.pdf |
| OECD - Why Mice Matter: Novel Systems for the Study of Human Disease from Basic Research to Applications - 1998 - (68 pages) | http://www.oecd.org/pdf/M000014000/M00014633.pdf |
| OECD - Technology Incubators: Nurturing Small Firms - 1997 - (129 pages) | http://www.oecd.org/pdf/M000014000/M00014673.pdf |
| OECD - Patents and Innovation in the International Context - 1997 - (36 pages) | http://www.oecd.org/pdf/M000014000/M00014675.pdf |
| OECD - The Evaluation of Scientific Research: Selected Experiences - 1997 - (112 pages) | http://www.oecd.org/pdf/M000014000/M00014831.pdf |
| OECD - Fiscal Measures to Promote R&D and Innovation - 1996 - (94 pages) | http://www.oecd.org/pdf/M000014000/M00014678.pdf |
| OECD - Directorate for Financial, Fiscal and Enterprise Affairs - Committee on Competition Law and Policy - Competition Policy and Intellectual Property Rights - September 1998 - DAFFE/CLP(98)18 - (458 pages) | http://www1.oecd.org/daf/clp/roundtables/IPR-GD.PDF |
| Council of Europe - CDBI - Projet de Protocole additionnel à la Convention sur les droits de l'Homme et la Biomédecine relatif à la transplantation d'organes et de tissus d'origine humaine et rapport explicatif - February 1999 - (30 pages) | http://www.nfp46.ch/downloads/law/ceprottp99.pdf |
| Council of Europe - Convention for the protection of Human Rights and dignity of the human being with regard to the application of biology and medicine: Convention on Human Rights and Biomedicine | http://conventions.coe.int/treaty/EN/WhatYouWant.asp?NT=164&CM=1&DF=22/03/01 |
| Council
of Europe - Projet de Protocole additionnel à la Convention sur les
Droits de l'Homme et la Biomédecine, relatif à la transplantation d'organes et de tissus d'origine humaine - (9 pages) |
http://www.bag.admin.ch/transpla/inter/f/Draft_PROTOCOL_TRANSP_250701.pdf |
| WTO - CANADA – TERM OF PATENT PROTECTION - Arbitration under Article 21.3(c) of the Understanding on Rules and Procedures Governing the Settlement of Disputes - (19 pages) | http://www.wto.org/english/tratop_e/dispu_e/170arb_e.pdf |
| WTO - Canada – PATENT PROTECTION OF PHARMACEUTICAL PRODUCTS - Arbitration under Article 21.3(c) of the Understanding on Rules and Procedures - Award of the Arbitrator James Bacchus -August 2000 - (21 pages) | http://www.wto.org/english/tratop_e/dispu_e/114abr_e.pdf |
| WTO
- Canada – Patent Protection of Pharmaceutical products - Complaint by
the European Communities and their member States Report of the panel - (March 2000) - (222 pages) |
http://www.wto.org/english/tratop_e/dispu_e/7428d.pdf |
| WTO - Canada – Term of Patent Protection - Report of the Panel - May 2000 - (163 pages in two parts) | http://www.wto.org/english/tratop_e/dispu_e/1391da.pdf http://www.wto.org/english/tratop_e/dispu_e/1391db.pdf |
| WTO, United States - Section 211 Omnibus Appropriations Act of 1998 - AB-2001-7 - Report of the Appellate Body | http://docsonline.wto.org/DDFDocuments/t/wt/ds/176ABR.doc |
| WHO - Overcoming Antimicrobial Resistance - World Health Report on Infectious Diseases 2000 - February 1, 2002 - (97 pages) | http://www.who.int/infectious-disease-report/2000/other_versions/index-rpt2000_text.html |
| United Nations Economic Commission for Africa - Organization of African Unity - Africa and the Multilateral Trading System Doha and Beyond - An Issues Paper - (32 pages) | http://www.uneca.org/eca_resources/Conference_Reports_and_Other_Documents/espd/2001/eca_oau/issue_paper.PDF |
| A. O. Adede - ICTSD - The Political Economy of the TRIPS Agreement: Origins and History of Negotiations - (36 pages) | http://www.ictsd.org/dlogue/2001-07-30/Adede.pdf |
| WIPO - Agenda for Development of the International Patent System - (15 pages) | http://www.wipo.int/eng/document/govbody/wo_gb_ab/pdf/a36_14.pdf |
| World Bank - Global Prospects and the Developing Countries 2002 - (271 pages) | http://www.worldbank.org/prospects/gep2002/gep2002complete.pdf |
| Carsten Fink - How Stronger Patent Protection in India Might Affect the Behavior or Transnational Pharmaceutical Industries - Development Research Group The World Bank - (46 pages) | http://econ.worldbank.org/docs/1106.pdf |
| European Patent Office - home page | http://www.european-patent-office.org/ |
| European Patent Office - Guidelines for examination (400 pages) | http://www.european-patent-office.org/legal/gui_lines/pdf/gui_e_full.pdf |
| Council for International Organizations of Medical Science ("CIOMS is an international, nongovernmental, non-profit-making organization established jointly by WHO and UNESCO in 1949.") | http://www.cioms.ch/ |
| World Trade Organization - home page | http://www.wto.org/ |
| Pharmaceutical Inspection Convention and Pharmaceutical Inspection Cooperation Scheme | http://www.picscheme.org/index.htm |
Last updated: July 7, 2002